Literature DB >> 15968199

Expression of CD10 and cytokeratins in ovarian and renal clear cell carcinoma.

Yoshiki Ohta1, Takao Suzuki, Akira Shiokawa, Toshiyuki Mitsuya, Hidekazu Ota.   

Abstract

A solid pattern of tumor cells with a clear cytoplasm is common to both ovarian clear cell carcinoma (OvCCC) and renal clear cell carcinoma (RCCC). This study examined the possible differential expression of CD10 and cytokeratins (CK7, CK20, 34betaE12, and CAM5.2) between these two types. An immunohistochemical technique using peroxidase-labeled amino acid polymers was used to test formalin-fixed and paraffin-embedded tissues. In OvCCC, 6 of 29 cases were positive for CD10, and all cases had expression of CK7, 34betaE12, and CAM5.2. In contrast, all 24 RCCC cases had CD10 and CAM5.2 immunoreactivity, but none had any staining for 34betaE12. CK7 was only expressed in nine cases. No CK20 positivity was observed in any sample from either tumor type. Localization of CD10 expression was different in OvCCC versus RCCC. Although positive staining for 34betaE12 strongly suggests OvCCC, sometimes only a few cells may be stained. Therefore, 34betaE12-negative biopsies also should be evaluated for CD10 and CK7 immunoreactivity to enable histologic and cytologic differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15968199     DOI: 10.1097/01.pgp.0000158533.28866.45

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  2 in total

1.  Fairly rare clear cell adenocarcinoma mimicking liver cancer: a case report.

Authors:  Norifumi Harimoto; Kei Hagiwara; Takahiro Yamanaka; Norihiro Ishii; Takamichi Igarashi; Akira Watanabe; Norio Kubo; Kenichirou Araki; Hayato Ikota; Masafumi Suyama; Takeshi Maki; Shinichi Aishima; Hiroyuki Kuwano; Ken Shirabe
Journal:  Surg Case Rep       Date:  2018-08-16

2.  Evaluating prognosis by CK7 differentiating renal cell carcinomas from oncocytomas can be used as a promising tool for optimizing diagnosis strategies.

Authors:  Fuling Ma; Liang Dai; Zhun Wang; Liqun Zhou; Yuanjie Niu; Ning Jiang
Journal:  Oncotarget       Date:  2016-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.